Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 10 out of 58Page size: 10
Sort by: Title
  1. Published

    2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde

    Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., van de Donk, N., Terpos, E., Broijl, A., de Larrea, C. F., Gay, F., Goldschmidt, H., Hajek, R., Vangsted, A. J., Zamagni, E., Zweegman, S., Cavo, M., Dimopoulos, M., Einsele, H., Ludwig, H., Barosi, G. & 4 others, Boccadoro, M., Mateos, M. V., Sonneveld, P. & Miguel, J. S., 2021, In: Haematologica. 106, 11, p. 2799-2812

    Research output: Contribution to journal › Review › Research › peer-review

  2. A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

    Erickson, S. W., Stephens, O. W., Chavan, S. S., Epstein, J., Barlogie, B., Heuck, C. J. & Vangsted, Annette Juul, Sep 2016, In: British Journal of Haematology. 174, 6, p. 991-993 3 p.

    Research output: Contribution to journal › Comment/debate › Research

  3. Published

    A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis

    Ríos-Tamayo, R., Lupiañez, C. B., Campa, D., Hielscher, T., Weinhold, N., Martinez-Lopez, J., Jerez, A., Landi, S., Jamroziak, K., Dumontet, C., Wątek, M., Lesueur, F., Reis, R. M., Marques, H., Jurczyszyn, A., Vogel, U., Buda, G., García-Sanz, R., Orciuolo, E., Petrini, M. & 8 others, Vangsted, Annette Juul, Gemignani, F., Försti, A., Goldschmidt, H., Hemminki, K., Canzian, F., Jurado, M. & Sainz, J., 2016, In: OncoTarget. 7, 37, p. 59029-59048 20 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma

    Vangsted, Annette Juul, Nielsen, K. R., Klausen, T. W., Haukaas, E., Tjønneland, A. & Vogel, U. B., 1 Aug 2012, In: British Journal of Haematology. 158, 4, p. 515-518 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    Dicanio, M., Giaccherini, M., Clay-Gilmour, A., Macauda, A., Sainz, J., Machiela, M. J., Rybicka-Ramos, M., Norman, A. D., Tyczyńska, A., Chanock, S. J., Barington, T., Kumar, S. K., Bhatti, P., Cozen, W., Brown, E. E., Suska, A., Haastrup, E. K., Orlowski, R. Z., Dudziński, M., Garcia-Sanz, R. & 42 others, Kruszewski, M., Martinez-Lopez, J., Beider, K., Iskierka-Jazdzewska, E., Pelosini, M., Berndt, S. I., Raźny, M., Jamroziak, K., Rajkumar, S. V., Jurczyszyn, A., Vangsted, Annette Juul, Collado, P. G., Vogel, U., Hofmann, J. N., Petrini, M., Butrym, A., Slager, S. L., Ziv, E., Subocz, E., Giles, G. G., Andersen, N. F., Mazur, G., Watek, M., Lesueur, F., Hildebrandt, M. A. T., Zawirska, D., Ebbesen, L. H., Marques, H., Gemignani, F., Dumontet, C., Várkonyi, J., Buda, G., Nagler, A., Druzd-Sitek, A., Wu, X., Kadar, K., Camp, N. J., Grzasko, N., Waller, R. G., Vachon, C., Canzian, F. & Campa, D., 2023, In: International Journal of Cancer. 152, 2, p. 239-248 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    A polygenic risk score for multiple myeloma risk prediction

    Canzian, F., Piredda, C., Macauda, A., Zawirska, D., Andersen, N. F., Nagler, A., Zaucha, J. M., Mazur, G., Dumontet, C., Wątek, M., Jamroziak, K., Sainz, J., Várkonyi, J., Butrym, A., Beider, K., Abildgaard, N., Lesueur, F., Dudziński, M., Vangsted, A. J., Pelosini, M. & 20 others, Subocz, E., Petrini, M., Buda, G., Raźny, M., Gemignani, F., Marques, H., Orciuolo, E., Kadar, K., Jurczyszyn, A., Druzd-Sitek, A., Vogel, U., Andersen, V., Reis, R. M., Suska, A., Avet-Loiseau, H., Kruszewski, M., Tomczak, W., Rymko, M., Minvielle, S. & Campa, D., 2022, In: European Journal of Human Genetics. 30, 4, p. 474-479 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support

    Vangsted, Annette Juul, Klausen, T. W., Gimsing, P., Andersen, N. F., Abildgaard, N., Gregersen, H. & Vogel, U., 2009, In: Haematologica. 94, 9, p. 1274-81 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

    Gregersen, H., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, N. F., Nielsen, L. K., Andersen, Christen Bertel L, Klausen, T. W., Vangsted, Annette Juul & Abildgaard, N., 2018, In: Experimental Hematology & Oncology. 7, 1, 18.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

    PRACTICAL consortium, P. C., 10 Jan 2019, In: Nature Communications. 10, 1, 3 p., 213.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Bisfosfonatassocieret osteonekrose i kaeberne hos patienter med myelomatose

    Lund, T., Gregersen, H., Vangsted, Annette Juul, Marker, P. & Abildgaard, N., 2009, In: Ugeskrift for læger. 171, 1-2, p. 50-2 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 Next

ID: 9762536